İnan Kıraç has been hospitalized, and his treatment is ongoing in the intensive care unit.

İnan Kıraç has been hospitalized, and his treatment is ongoing in the intensive care unit.

28.08.2025 22:20

One of the prominent figures in the business world, İnan Kıraç, has been admitted to intensive care at the American Hospital due to a deterioration in his health condition. His daughter, İpek Kıraç, who had been estranged from him for a long time but reconciled in recent weeks, is closely monitoring his treatment process.

The son-in-law of the Koç Family, İnan Kıraç, the founder of Kıraça Holding, was taken to intensive care at the American Hospital after his health deteriorated during the ongoing treatment process at home. It was reported that the process is being closely monitored due to the hospital being owned by the Koç Family.

THE RIFT HAS ENDED

According to news from Patronlar Dünyası, Kıraç's daughter, İpek Kıraç, is by his side during the intensive care process. After years of estrangement, father and daughter had recently reunited at a private hospital in Ümraniye. This meeting was seen as a sign of reconciliation within the family.

İnan Kıraç has been hospitalized, his treatment continues in intensive care

EMOTIONAL REUNION REFLECTED TO THE PUBLIC

The photo of İpek Kıraç hugging her father during her visit to the hospital room had a wide impact on the public. The first contact after years drew attention both within the family circle and in the business world.

THE TREATMENT PROCESS IS BEING CLOSELY MONITORED

It has been learned that İnan Kıraç is being kept under observation in intensive care, and his treatment is being carried out with the assistance of specialist doctors. It is reported that İpek Kıraç has not left her father's side, is closely following the process, and is continuously receiving information about his health status.

In order to provide you with a better service, we position cookies on our site. Your personal data is collected and processed within the scope of KVKK and GDPR. For detailed information, you can review our Data Policy / Disclosure Text. By using our site, you agree to our use of cookies.', '